Insider Selling: Axcelis Technologies (NASDAQ:ACLS) Director Sells 1,789 Shares of Stock

Axcelis Technologies, Inc. (NASDAQ:ACLSGet Free Report) Director Jeanne Quirk sold 1,789 shares of the stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $140.22, for a total transaction of $250,853.58. Following the completion of the sale, the director directly owned 11,400 shares in the company, valued at approximately $1,598,508. The trade was a 13.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Axcelis Technologies Price Performance

NASDAQ ACLS traded up $6.33 during trading hours on Wednesday, reaching $149.56. The company’s stock had a trading volume of 386,214 shares, compared to its average volume of 781,032. The stock has a market cap of $4.60 billion, a PE ratio of 46.59, a PEG ratio of 11.64 and a beta of 1.93. Axcelis Technologies, Inc. has a fifty-two week low of $55.93 and a fifty-two week high of $171.61. The company’s 50-day moving average is $117.06 and its two-hundred day moving average is $96.90. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.59.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last issued its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $198.96 million for the quarter, compared to analysts’ expectations of $195.03 million. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The firm’s revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.88 EPS. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Analysts forecast that Axcelis Technologies, Inc. will post 2.86 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. UBS Group AG lifted its holdings in Axcelis Technologies by 67.6% in the 4th quarter. UBS Group AG now owns 213,388 shares of the semiconductor company’s stock valued at $17,144,000 after purchasing an additional 86,065 shares in the last quarter. Summit Global Investments acquired a new stake in shares of Axcelis Technologies in the third quarter worth approximately $789,000. AlphaQuest LLC acquired a new stake in shares of Axcelis Technologies in the third quarter worth approximately $1,347,000. Oliver Luxxe Assets LLC acquired a new stake in shares of Axcelis Technologies in the fourth quarter worth approximately $1,451,000. Finally, Old West Investment Management LLC acquired a new stake in shares of Axcelis Technologies in the third quarter worth approximately $1,588,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ACLS shares. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price objective on the stock in a research note on Monday, April 20th. Weiss Ratings lowered shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Finally, Zacks Research upgraded shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $116.25.

Get Our Latest Report on Axcelis Technologies

About Axcelis Technologies

(Get Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Read More

Insider Buying and Selling by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.